36.6 F
New York
Wednesday, January 27, 2021

Moderna Inc.’s [NASDAQ: MRNA] Board Member Dr. Nabel Resigns

Must read

Nova Lifestyle [NASDAQ: NVFY] Announces The Inauguration Of HealthLine Membership In The Malaysian Market

Nova lifestyle revealed that the company is planning to inaugurate a HealthLine platform based on membership in Malaysia. The company recently launched an...

JPMorgan [NYSE: JPM] Announced To Initiate A Digital Retail Bank In The United Kingdom

JPMorgan Chase revealed that the company will launch a new digital retail bank in the United Kingdom offering the customer of the region...

Humanigen [NASDAQ: HGEN] Announces Expansion Of Manufacturing Agreement With Ajinomoto Bio-Pharma

Humanigen Inc revealed that the company has extended the manufacturing agreement with  Ajinomoto BioPharma to support the fill-finish of Lenzilumab. The Lenzilumab is...

Synchrony [NYSE: SYF] Announced To Purchase Allegro Credit

Synchrony Financials revealed that the company entered into a definitive contract to Purchase Allegro Credit. Allegro Credit's customer base and merchant network will...

Moderna Inc.[NASDAQ: MRNA], a clinical-stage biotechnology company disclosed that Dr. Nabel Elizabeth from the board of directors resigned. She is the president of Brigham and Women’s Hospital.

Brigham and Women’s Hospital is one of the 89 clinical trial sites in the phase 3 trial of mRNA-1273, a vaccine candidate against COVID-19 of Moderna. Noubar Afeyan, Ph.D., Co-Founder and Chairman of Moderna, and CEO of Flagship Pioneering thanked her for her services in Moderna Board.

Shares of Moderna Inc. dropped 2.36% at $77.63 during the trading of Thursday. It has day low and day high range of $76.80-$79.25, respectively. It had trading volume of 13 million as compared to the avearge volume of 27.17 million.

In the past 52-weeks of trading this company’s stocks have fluctuated between the low of $11.54 and a high of $95.21. It has moved up 572.70% from 52-weeks low and moved down -18.46% from its 52-weeks high.

If we look at its profitability, its return on assets (ROA) is -29.20%, return on equity (ROE) is -37.40%, and return on investment (ROI) is -44.90%. It has recorded the sales of 52.60 million.

Her experience as a clinician and global health leader played a very important role in the progress of Moderna Inc. She has been served in Moderna’s board of directors for five years.

Moderna has accepted her resignation to avoid any conflict of interest amid the Phase 3 trial of the coronavirus vaccine candidate. Moderna Inc has started its late-stage human trials on Monday with the collaboration with the National Institute of Allergy and Infectious Diseases.

More articles

Latest article

Vericel Corp [NASDAQ: VCEL] Names Joe Mara As The New CFO

Vericel Corporation revealed that the company has named Joe Mara as the CFO of the company. He has over more than 20 years...

A Paychex [NASDAQ: PAYX] Subsidiary Announces Strategic Collaboration With Zoho Books

SurePayroll, a subsidiary of Paychex company revealed that the company has formed a collaboration with Zoho books. SurePAyroll is a provider of small...

MGP Ingredients [NASDAQ: MGPI] Announced To Acquire Luxco and Its Affiliate Companies

MGP Ingredients  revealed a definitive contract to purchase Luxco, Inc and its affiliated companies. Luxco is an alcohol beverage company with more than 60...

Conformis [NASDAQ: CFMS] Entered A Non-Exclusive agreement with SITES Medical

Conformis Inc revealed that the company inked a development and supply contract with sites medical. Both of the companies will work together to...

Colliers International [NASDAQ: CIGI] Announces Executive Leadership Changes For Australian Business

Colliers International  reported that the company has named Malcom Tyson as the new Chief Executive Officer. He is appointed as the CEO so...

Korn Ferry [NYSE: KFY] Announces Expansion Of Its Footprint In Russian Market

Korn Fery revealed that the company is expanding its footprint in Russia. Moreover, it is adding a high expertise team of executive search...

Haemonetics [NYSE: HAE] To Purchase Cardiva For An Upfront Payment Of $475M

Haemonetics Corporation revealed that the company has inked a definitive contract to purchase Cardiva Medical Inc. Under the contract, Haemontics will pay an...

Philips [NYSE: PHG] To Purchase Capsule Technologies For Cash Consideration Of USD 635M

Koninklijke Philip revealed that the company has inked a contract to purchase Capsule technologies. The company will pay a cash price of $636...